Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.
about
Acute thyroid eye disease (TED): principles of medical and surgical managementBreaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticlesConcise review: the periosteum: tapping into a reservoir of clinically useful progenitor cellsCurrent concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Differential Role of Adipose Tissues in Obesity and Related Metabolic and Vascular ComplicationsGraves' ophthalmopathySkin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulin-expressing clusters: a transgene-free approachExercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function.A putative role for platelet-derived PPARγ in vascular homeostasis demonstrated by anti-PPARγ induction of bleeding, thrombocytopenia and compensatory megakaryocytopoiesisAnticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes.Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy.Novel anti-adipogenic activity produced by human fibroblasts.Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implicationsΔ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in miceThe aryl hydrocarbon receptor ligand ITE inhibits TGFβ1-induced human myofibroblast differentiationPerivascular adipose tissue and its role in type 2 diabetes and cardiovascular diseasePeroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism.Inhibitory effects of PPARγ ligands on TGF-β1-induced corneal myofibroblast transformation.The Role of PPARs in Lung Fibrosis.Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans.Quantitative MRI analysis of salivary glands in sickle cell disease.Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathyRegulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related InflammationRole of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignanciesImmune mechanisms in thyroid eye disease.Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.Peroxisome proliferator-activated receptor-gamma ligands induce heme oxygenase-1 in lung fibroblasts by a PPARgamma-independent, glutathione-dependent mechanism.Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes.Proinflammatory and immunoregulatory roles of eicosanoids in T cells.Polyunsaturated Fatty Acid-derived lipid mediators and T cell function.Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.Prostaglandin E2 signals white-to-brown adipogenic differentiation.Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring.Mast cell-derived prostaglandin D2 controls hyaluronan synthesis in human orbital fibroblasts via DP1 activation: implications for thyroid eye disease.Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxibMast cells function as an alternative modulator of adipogenesis through 15-deoxy-delta-12, 14-prostaglandin J2.
P2860
Q26827429-5A216ACC-8A7B-4660-8410-E896FAB737A0Q26830366-8FB35CFB-8C8C-47CA-AED2-FB86D1BCEA70Q26859064-9C6DB38E-3937-449E-80A4-66C8F0F83CAEQ27691806-5BD3688C-3FEA-4219-8E6A-35D2A010CDE0Q28069452-E1849E29-8758-46C0-9F60-A92D7790D4D3Q28274196-B5A64F8D-F408-4167-86E4-0F8F7DED37D7Q28540003-0B094625-546E-4345-9714-84109E311147Q30238666-7D21DCB6-FDF9-41E3-919F-EF72CDCC7BF4Q33392128-0B35BA54-B3AC-470C-958F-1D7F9FAF734CQ33692555-94999C29-AEF7-49F3-8572-86AA320F9D11Q34062319-1F9DE9AF-5759-46BE-AB0F-1C6F0AF61F09Q34149741-6D2A6B93-51AC-4717-9790-9C5846954739Q34275875-B301E5A1-B237-4FC3-AE14-6E370C34C895Q34632798-9CAB6112-3148-4FBC-90E2-9755D425975DQ34805707-AD3662CE-E446-45D5-AF97-B8670C6281DAQ34902082-C9C90B4A-6219-4F22-9BFE-98C1D98A0B81Q34998187-D13F5DE7-1725-4F34-972B-246900DC02DBQ35101448-916F9D98-DBC6-41EC-90B2-4A6A7E533257Q35125945-F61060E2-BCA7-4226-8EEE-F766BB463A16Q35925362-AFEDCC75-B67A-41D1-88B9-176A43A915A2Q35927429-C731EEAD-444C-4CDA-A6DA-FEFC2E6F2658Q36482598-53C8909E-F82D-4070-8E96-E0CE62C59BC8Q36951623-55C286F4-478F-4B79-82FC-0826A7916258Q37017200-8D841EBA-8C54-4945-8343-9F28D61EE76BQ37114625-033FCAF3-1FDD-446E-BB76-A9FC38A3CA4EQ37182794-0C75D632-02FF-44F9-856D-2CE63C7DBDC5Q37254482-70B0C85D-36E0-4C55-A197-36C593F72F18Q37296579-C671CD28-7AF4-44D3-81D2-36643F6FA6D8Q37421267-05724C47-4893-411E-8272-C01AD1CB147DQ38082465-8C9C4C29-7BCC-47E9-8D0F-5DDE678E9882Q38113934-8D90F599-6DC3-4CFC-8261-5237EAEA70A1Q38194553-8CA2ACCF-F09F-47B6-BA28-4992AC7D7566Q38355897-D63040E5-EA3B-4139-8D61-323E9C745E09Q38575787-C630CFEF-E49B-4617-9114-44689A9F589FQ40430999-207EE8A6-22D5-4FC0-B6D0-E44934796EEEQ40601963-66903C22-2144-46C7-9519-9CAD120D0850Q41807857-99A899F3-7E9B-4E19-AEF2-89797E155E52Q42210954-F28C79D8-607D-4777-A76A-201C1BCD529EQ42566773-617E533D-D1F1-499A-AD4F-292461B78AADQ42806486-9EFB438B-80FF-4EF0-8577-7ADE817FFF27
P2860
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Activated human T lymphocytes ...... differentiation to adipocytes.
@ast
Activated human T lymphocytes ...... differentiation to adipocytes.
@en
type
label
Activated human T lymphocytes ...... differentiation to adipocytes.
@ast
Activated human T lymphocytes ...... differentiation to adipocytes.
@en
prefLabel
Activated human T lymphocytes ...... differentiation to adipocytes.
@ast
Activated human T lymphocytes ...... differentiation to adipocytes.
@en
P2093
P2860
P1476
Activated human T lymphocytes ...... differentiation to adipocytes.
@en
P2093
Charles W O'loughlin
Denise M Ray
Kathryn E Seweryniak
Richard P Phipps
Shira Landskroner-Eiger
Steven E Feldon
P2860
P304
P356
10.2353/AJPATH.2006.060434
P407
P577
2006-10-01T00:00:00Z